SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-24-002541
Filing Date
2024-03-06
Accepted
2024-03-06 07:19:47
Documents
114
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K aplt-20231231x10k.htm   iXBRL 10-K 2789222
2 EX-23.1 aplt-20231231xex23d1.htm EX-23.1 9358
3 EX-31.1 aplt-20231231xex31d1.htm EX-31.1 9305
4 EX-31.2 aplt-20231231xex31d2.htm EX-31.2 9326
5 EX-32.1 aplt-20231231xex32d1.htm EX-32.1 5830
6 EX-32.2 aplt-20231231xex32d2.htm EX-32.2 5927
7 EX-97.1 aplt-20231231xex97d1.htm EX-97.1 44391
8 GRAPHIC aplt-20231231x10k001.jpg GRAPHIC 5292
9 GRAPHIC aplt-20231231x10k002.jpg GRAPHIC 88935
10 GRAPHIC aplt-20231231x10k003.jpg GRAPHIC 39451
11 GRAPHIC aplt-20231231x10k005.jpg GRAPHIC 32679
12 GRAPHIC aplt-20231231x10k007.jpg GRAPHIC 51899
13 GRAPHIC aplt-20231231x10k009.jpg GRAPHIC 43957
  Complete submission text file 0001558370-24-002541.txt   11597898

Data Files

Seq Description Document Type Size
14 EX-101.SCH aplt-20231231.xsd EX-101.SCH 86881
15 EX-101.CAL aplt-20231231_cal.xml EX-101.CAL 67397
16 EX-101.DEF aplt-20231231_def.xml EX-101.DEF 334085
17 EX-101.LAB aplt-20231231_lab.xml EX-101.LAB 675455
18 EX-101.PRE aplt-20231231_pre.xml EX-101.PRE 584059
116 EXTRACTED XBRL INSTANCE DOCUMENT aplt-20231231x10k_htm.xml XML 1600704
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38898 | Film No.: 24724368
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)